Growth Metrics

Acadia Pharmaceuticals (ACAD) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -13.32%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -10.19%
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 24.11%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 3.92%
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn 318.87%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 318.87%
Dec 31, 2025 78.20%
Sep 30, 2025 -7.02%
Jun 30, 2025 -14.41%
Mar 31, 2025 -19.95%
Dec 31, 2024 -8.61%
Sep 30, 2024 -18.35%
Jun 30, 2024 -20.20%
Mar 31, 2024 -21.89%
Dec 31, 2023 -23.40%
Sep 30, 2023 -24.98%
Jun 30, 2023 -25.98%
Mar 31, 2023 -25.71%
Dec 31, 2022 -25.18%
Sep 30, 2022 -24.13%
Jun 30, 2022 -23.71%
Mar 31, 2022 -22.81%
Dec 31, 2021 -12.16%
Sep 30, 2021 1.83%
Jun 30, 2021 37.54%
Mar 31, 2021 91.73%
Dec 31, 2020 188.08%
Sep 30, 2020 159.37%
Jun 30, 2020 95.13%
Mar 31, 2020 36.18%
Dec 31, 2019 -3.90%
Sep 30, 2019 -3.65%
Jun 30, 2019 24.17%
Mar 31, 2019 37.95%
Dec 31, 2018 24.31%
Sep 30, 2018 12.74%
Jun 30, 2018 -16.26%
Mar 31, 2018 -21.95%
Dec 31, 2017 -13.60%
Sep 30, 2017 -5.32%
Jun 30, 2017 13.77%
Mar 31, 2017 32.33%
Dec 31, 2016 39.85%
Sep 30, 2016 52.76%
Jun 30, 2016 59.79%
Mar 31, 2016 46.86%
Dec 31, 2015 298.37%
Sep 30, 2015 297.69%
Jun 30, 2015 262.60%
Mar 31, 2015 228.91%
Dec 31, 2014 -4.49%
Sep 30, 2014 6.12%
Jun 30, 2014 443.48%
Mar 31, 2014 1,710.00%
Dec 31, 2013 1,278.57%
Sep 30, 2013 677.78%
Jun 30, 2013 0.00%
Mar 31, 2013 -75.21%
Dec 31, 2012 -72.19%
Sep 30, 2012 -65.19%
Jun 30, 2012 -55.77%
Dec 31, 2011 -64.55%